SCHEMBL3220008

SCHEMBL3220008

COc1cc(OC)c2[nH]cc(/C=C/[N+](=O)[O-])c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 2/20 0.44
HTT P42858 2/20 0.44
MITF O75030 1/20 0.44
HSP90AA1 P07900 1/20 0.44
PRMT1 Q99873 1/20 0.44
VCP P55072 3/20 0.43
FBP1 P09467 2/20 0.42
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
GALR2 O43603 1/20 0.40
EGFR P00533 1/20 0.40
SYK P43405 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NQO2 P16083 2/20 0.39
NLRP3 Q96P20 1/20 0.38
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3214421 1.00 ALDH1A1 (0.44) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL30483777 0.86 FBP1 (0.41) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL2537636 0.80 PRMT1 (0.58) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL30740811 0.80 PRMT1 (0.58) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL29103652 0.80 PRMT1 (0.58) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL2537633 0.80 PRMT1 (0.58) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL3210719 0.79 ALDH1A1 (0.56) ALDH1A1MAPTMTNR1AMTNR1BNQO2
SCHEMBL3010462 0.77 ALDH1A1 (0.63) ALDH1A1LMNAMAPTMITFFBP1
SCHEMBL3010460 0.77 ALDH1A1 (0.63) ALDH1A1LMNAMAPTMITFFBP1
SCHEMBL31451378 0.75 MTNR1A (0.44) ALDH1A1LMNAMAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8258173-B2 Melatonin derivatives and their use as antioxidants UNIVERSITY OF SUNDERLAND (GB) 2012-09-04 US disclosed
US-20100063125-A1 MELATONIN DERIVATIVES AND THEIR USE AS ANTIOXIDANTS UNIVERSITY OF SUNDERLAND (GB) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063125-A1 MELATONIN DERIVATIVES AND THEIR USE AS ANTIOXIDANTS MTNR1A, MTNR1B, TXNRD2 ALDH1A1 250/4885LMNA 2090/4885MAPT 2221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.